Indian equities posted their steepest weekly fall in seven months as the Sensex and Nifty extended losses amid U.S. visa curbs and drug tariffs. Pharma and IT stocks dragged, while FIIs stayed cautious. Analysts flagged key support at 24,500, with volatility expected around monthly expiry and global uncertainties weighing on sentiment.
Sensex, Nifty rally over 1% as IT stocks drive broad-based market gains
Indian stock gauges rose over one percent on Wednesday. Overseas fund flows are expected to shift into local technology companies. The Nifty and Sensex closed